1. Pink Sheet
  2. >>Compliance

The Quality Lowdown: Spanish Falsification, Czech Mold And Dutch Contamination Cited After EU Lull Ends

 
• By Bowman Cox

Barcelona’s Union Quimico, Czech Republic’s Vakos and The Netherlands’ Pharma Essentials among those cited as the EMA ramps up in Amsterdam.

The Quality Lowdown

A Spanish maker of active pharmaceutical ingredients was slammed for obstructing inspectors and falsifying data, while Czech and Italian firms were chastised for lack of sterility assurance as European pharmaceutical inspectorates emerged from the European Medicines Agency’s Brexit-move-related hiatus with vigor, judging from EU GMP noncompliance statements published over the past month.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Pink Sheet

Japan Looks To Build Domestic Capacity In New Modalities

 
• By Lisa Takagi

Japan's trade ministry is providing new support to build domestic capacity for new modalities including cell and gene therapies, as part of wider efforts to support the national bioventure ecosystem.

GLP-1 Drug Coverage Growing For Obesity In Medicaid, But Only For Diabetes In Medicare

 
• By Cathy Kelly

Coverage data from the two programs suggest Medicare beneficiaries may be more disappointed than Medicaid enrollees by the Trump Administration’s decision not to mandate the programs cover obesity drugs.

US FDA Allows Telework For Reviewers As Companies Detail Layoff-Related Problems

 
• By Derrick Gingery

The new telework policy returns to the pre-COVID-19 pandemic standard, but still requires reviewers to be at White Oak for sponsor meetings and divisions to have an in-office presence every day.